Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Parikh

Showing results (321-330 of 385) with videos related to

Pageof 39
Sort By:
Science Advances|February 11, 2021
Molecular characterization of the human kidney interstitium in health and diseaseDaria Barwinska, Tarek M El-Achkar, Ricardo Melo Ferreira, et al.
ESC Heart Failure|May 1, 2026
Real-World Incidence of Cancer Therapy-Related Cardiac Dysfunction in a Large, Diverse, and Contemporary CohortSamir R Thadani, Alan S Go, Jane Y Liu, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological TreatmentsSidney H Kennedy, Raymond W Lam, Roger S McIntyre, et al.
Journal of Affective Disorders|January 24, 2020
Reverse translation of major depressive disorder symptoms: A framework for the behavioural phenotyping of putative biomarkersStephen Daniels, Thomas Horman, Thomas Lapointe, et al.
Psychiatry Research|December 25, 2021
Evaluating the perceived utility of an artificial intelligence-powered clinical decision support system for depression treatment using a simulation centerMyriam Tanguay-Sela, David Benrimoh, Christina Popescu, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 26, 2025
Modulation of Brain Temporal Complexity During Treatment for Depression: A CAN-BIND-1 Study Report: Modulation de la complexité temporelle du cerveau pendant le traitement de la dépression: rapport de l'étude CAN-BIND-1Chloé Stengel, Benjamin Schwartzmann, Raaj Chatterjee, et al.
Journal of the American College of Cardiology|July 30, 2025
Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure With Improved Ejection FractionKyung H Min, Alan S Go, Keane Lee, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|January 15, 2022
Response Inhibition and Predicting Response to Pharmacological and Cognitive Behavioral Therapy Treatments for Major Depressive Disorder: A Canadian Biomarker Integration Network for Depression StudyPrabhjot Dhami, Lena C Quilty, Benjamin Schwartzmann, et al.
Bipolar Disorders|December 15, 2012
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013Lakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, et al.
Journal of the American Heart Association|September 30, 2023
Developing Clinical Risk Prediction Models for Worsening Heart Failure Events and Death by Left Ventricular Ejection FractionRishi V Parikh, Alan S Go, Ankeet S Bhatt, et al.
Pageof 39

Showing results (321-330 of 385) with videos related to

Sort By:
Pageof 39
Science Advances|February 11, 2021
Molecular characterization of the human kidney interstitium in health and diseaseDaria Barwinska, Tarek M El-Achkar, Ricardo Melo Ferreira, et al.
ESC Heart Failure|May 1, 2026
Real-World Incidence of Cancer Therapy-Related Cardiac Dysfunction in a Large, Diverse, and Contemporary CohortSamir R Thadani, Alan S Go, Jane Y Liu, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological TreatmentsSidney H Kennedy, Raymond W Lam, Roger S McIntyre, et al.
Journal of Affective Disorders|January 24, 2020
Reverse translation of major depressive disorder symptoms: A framework for the behavioural phenotyping of putative biomarkersStephen Daniels, Thomas Horman, Thomas Lapointe, et al.
Psychiatry Research|December 25, 2021
Evaluating the perceived utility of an artificial intelligence-powered clinical decision support system for depression treatment using a simulation centerMyriam Tanguay-Sela, David Benrimoh, Christina Popescu, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 26, 2025
Modulation of Brain Temporal Complexity During Treatment for Depression: A CAN-BIND-1 Study Report: Modulation de la complexité temporelle du cerveau pendant le traitement de la dépression: rapport de l'étude CAN-BIND-1Chloé Stengel, Benjamin Schwartzmann, Raaj Chatterjee, et al.
Journal of the American College of Cardiology|July 30, 2025
Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure With Improved Ejection FractionKyung H Min, Alan S Go, Keane Lee, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|January 15, 2022
Response Inhibition and Predicting Response to Pharmacological and Cognitive Behavioral Therapy Treatments for Major Depressive Disorder: A Canadian Biomarker Integration Network for Depression StudyPrabhjot Dhami, Lena C Quilty, Benjamin Schwartzmann, et al.
Bipolar Disorders|December 15, 2012
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013Lakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, et al.
Journal of the American Heart Association|September 30, 2023
Developing Clinical Risk Prediction Models for Worsening Heart Failure Events and Death by Left Ventricular Ejection FractionRishi V Parikh, Alan S Go, Ankeet S Bhatt, et al.
Pageof 39